J Natl Compr Canc Netw 22

HSR24-160: Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus: Patient
Characteristics, Clinical Outcomes, and Survival Implications of Autoantibodies.

Sharp J, Pasadyn C, Zhao S, Wei L, Presley C, Owen D, Wyne K, Meara A